• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液中MxA mRNA与早期多发性硬化症长期疾病活动之间的关联。

The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis.

作者信息

Coerver Eline M E, Strijbis Eva M M, Petzold Laura F, Van Kempen Zoé L E, Jasperse Bas, Barkhof Frederik, Oudejans Cees B M, Uitdehaag Bernard M J, Teunissen Charlotte E, Killestein Joep

机构信息

Department of Neurology, MS Center Amsterdam, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Department of Neurology, Maidstone and Tunbridge Wells NHS Trust, Kent, United Kingdom.

出版信息

Front Neurol. 2022 Aug 17;13:907245. doi: 10.3389/fneur.2022.907245. eCollection 2022.

DOI:10.3389/fneur.2022.907245
PMID:36062003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9428291/
Abstract

BACKGROUND

Myxovirus resistance protein A (MxA) is a protein that is upregulated by interferon-beta. Homeostatic MxA mRNA levels are potentially correlated with inflammatory disease activity in multiple sclerosis (MS) and could have an important role in MS pathology.

AIM

To investigate the association between myxovirus resistance protein A (MxA) mRNA levels in blood and disease activity and progression in MS over a long-term follow-up period.

METHODS

Baseline blood MxA mRNA levels were determined in a prospective cohort of 116 untreated patients with a clinically isolated syndrome (CIS) or early relapsing remitting MS (RRMS), and related to long-term relapses, radiological disease activity, clinical scores [Expanded Disability Status Scale (EDSS), timed-25-foot walk (T25FW), 9-hole-peg test (9HPT)], MS type, and disease modifying therapy (DMT) use.

RESULTS

Low MxA mRNA levels were associated with the occurrence of ≥9 T2-lesions on MRI imaging and the occurrence of relapses during long-term follow-up (median 11 years, IQR 5.91-13.69 years). MxA mRNA levels were not associated with EDSS, T25FW, 9HPT, and MS subtype.

CONCLUSION

Baseline MxA mRNA levels are associated with long-term development of T2-lesions on MRI-scans in our cohort. This confirms the relevance of the endogenous interferon-beta system in the occurrence of MS disease activity.

摘要

背景

黏液病毒抗性蛋白A(MxA)是一种受β干扰素上调的蛋白质。稳态MxA mRNA水平可能与多发性硬化症(MS)的炎症疾病活动相关,并可能在MS病理过程中发挥重要作用。

目的

在长期随访期间,研究血液中黏液病毒抗性蛋白A(MxA)mRNA水平与MS疾病活动及进展之间的关联。

方法

测定了116例未经治疗的临床孤立综合征(CIS)或早期复发缓解型MS(RRMS)患者前瞻性队列中的基线血液MxA mRNA水平,并将其与长期复发、放射学疾病活动、临床评分[扩展残疾状态量表(EDSS)、25英尺步行时间(T25FW)、9孔插钉试验(9HPT)]、MS类型和疾病修饰治疗(DMT)的使用情况相关联。

结果

低MxA mRNA水平与MRI成像上≥9个T2病变的出现以及长期随访期间(中位时间11年,四分位间距5.91 - 13.69年)的复发相关。MxA mRNA水平与EDSS、T25FW、9HPT及MS亚型无关。

结论

在我们的队列中,基线MxA mRNA水平与MRI扫描上T2病变的长期发展相关。这证实了内源性β干扰素系统在MS疾病活动发生中的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14a/9428291/996b45f98afa/fneur-13-907245-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14a/9428291/996b45f98afa/fneur-13-907245-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b14a/9428291/996b45f98afa/fneur-13-907245-g0001.jpg

相似文献

1
The association between blood MxA mRNA and long-term disease activity in early multiple sclerosis.血液中MxA mRNA与早期多发性硬化症长期疾病活动之间的关联。
Front Neurol. 2022 Aug 17;13:907245. doi: 10.3389/fneur.2022.907245. eCollection 2022.
2
Predictors of Health Utility in Relapsing-Remitting and Secondary-Progressive Multiple Sclerosis: Implications for Future Economic Models of Disease-Modifying Therapies.复发缓解型和继发进展型多发性硬化症患者健康效用的预测因素:对疾病修正治疗未来经济模型的启示。
Pharmacoeconomics. 2021 Feb;39(2):243-256. doi: 10.1007/s40273-020-00964-w. Epub 2020 Sep 29.
3
Inverse Relation between MxA Gene Expression and Age in Multiple Sclerosis Patients Reveals a Gender Difference in Response to Interferon Therapy.多发性硬化症患者中MxA基因表达与年龄的负相关揭示了干扰素治疗反应中的性别差异。
Iran J Allergy Asthma Immunol. 2017 Feb;16(1):21-27.
4
Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFNβ.干扰素β治疗的多发性硬化症患者中抗黏液病毒蛋白A mRNA的表达动力学
PLoS One. 2017 Jan 12;12(1):e0169957. doi: 10.1371/journal.pone.0169957. eCollection 2017.
5
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.MxA 诱导缺失与多发性硬化症患者对干扰素 β 治疗的临床反应不佳有关。
J Neurol. 2016 Apr;263(4):722-9. doi: 10.1007/s00415-016-8053-z. Epub 2016 Feb 12.
6
MicroRNA-29b variants and MxA expression change during interferon beta therapy in patients with relapsing-remitting multiple sclerosis.微小 RNA-29b 变体和 MxA 表达在复发缓解型多发性硬化症患者接受干扰素β治疗期间的变化。
Mult Scler Relat Disord. 2019 Oct;35:241-245. doi: 10.1016/j.msard.2019.07.034. Epub 2019 Jul 31.
7
Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.使用多水平模型对复发缓解型多发性硬化症的疾病进展进行建模,该模型应用于来自两个自然史队列和一个治疗队列的纵向数据。
Health Technol Assess. 2016 Oct;20(81):1-48. doi: 10.3310/hta20810.
8
MxA mRNA quantification and disability progression in interferon beta-treated multiple sclerosis patients.干扰素β治疗的多发性硬化症患者中MxA mRNA定量与残疾进展
PLoS One. 2014 Apr 14;9(4):e94794. doi: 10.1371/journal.pone.0094794. eCollection 2014.
9
Clinico-radiological dissociation of disease activity in MS patients: frequency and clinical relevance.MS 患者疾病活动的临床-放射学分离:频率和临床相关性。
J Neurol. 2020 Nov;267(11):3287-3291. doi: 10.1007/s00415-020-09991-1. Epub 2020 Jun 20.
10
Baseline MxA mRNA expression predicts interferon beta response in multiple sclerosis patients.基线MxA mRNA表达可预测多发性硬化症患者对干扰素β的反应。
PLoS One. 2014 Nov 14;9(11):e112758. doi: 10.1371/journal.pone.0112758. eCollection 2014.

本文引用的文献

1
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.纵向分析显示,多发性硬化症与 Epstein-Barr 病毒的高患病率相关。
Science. 2022 Jan 21;375(6578):296-301. doi: 10.1126/science.abj8222. Epub 2022 Jan 13.
2
Investigation of IL-2 and IFN-γ to EBV Peptides in Stimulated Whole Blood among Multiple Sclerosis Patients and Healthy Individuals.多发性硬化症患者和健康个体中,白细胞介素-2和干扰素-γ对刺激全血中EBV肽的研究。
Intervirology. 2021;64(4):203-208. doi: 10.1159/000517002. Epub 2021 Jun 25.
3
Role of Viruses in the Pathogenesis of Multiple Sclerosis.
病毒在多发性硬化症发病机制中的作用。
Viruses. 2020 Jun 13;12(6):643. doi: 10.3390/v12060643.
4
Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.EBV 衣壳蛋白 BGLF2 抑制 I 型干扰素信号通路以促进 EBV 再激活。
J Virol. 2020 May 18;94(11). doi: 10.1128/JVI.00258-20.
5
Systemic lupus erythematosus: Diagnosis and clinical management.系统性红斑狼疮:诊断与临床管理。
J Autoimmun. 2019 Jan;96:1-13. doi: 10.1016/j.jaut.2018.11.001. Epub 2018 Nov 16.
6
Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis.多发性硬化症 III 期临床试验中的残疾结局测量。
CNS Drugs. 2018 Jun;32(6):543-558. doi: 10.1007/s40263-018-0530-8.
7
Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.25英尺定时步行作为多发性硬化症动态表现结果测量指标的有效性。
Mult Scler. 2017 Apr;23(5):704-710. doi: 10.1177/1352458517690823. Epub 2017 Feb 16.
8
The Nine-Hole Peg Test as a manual dexterity performance measure for multiple sclerosis.九孔插板测试作为多发性硬化症手部灵巧性的一项性能指标。
Mult Scler. 2017 Apr;23(5):711-720. doi: 10.1177/1352458517690824. Epub 2017 Feb 16.
9
Type I/II Interferon Balance in the Regulation of Brain Physiology and Pathology.I 型/II 型干扰素平衡在大脑生理学和病理学中的调节作用。
Trends Immunol. 2016 Mar;37(3):181-192. doi: 10.1016/j.it.2016.01.006. Epub 2016 Feb 11.
10
Endogenous interferon-β-inducible gene expression and interferon-β-treatment are associated with reduced T cell responses to myelin basic protein in multiple sclerosis.内源性干扰素-β诱导基因表达和干扰素-β治疗与多发性硬化症中T细胞对髓鞘碱性蛋白的反应降低有关。
PLoS One. 2015 Mar 4;10(3):e0118830. doi: 10.1371/journal.pone.0118830. eCollection 2015.